CSO Yocca Frank Continues Quiet Accumulation at BioXcel, Signaling Insider Confidence Ahead of Key Drug‑Discovery Milestones
BioXcel insider buying: CSO Yocca Frank’s recent 68‑share purchase signals confidence in the AI‑driven drug platform and may hint at upcoming upside for investors.
3 minutes to read

